25I-NBOMe (original) (raw)
25I-NBOMe (oder 2C-I-NBOMe) ist eine Forschungschemikalie mit halluzinogener und psychedelischer Wirkung, die aufgrund ihrer Struktur zu den Stoffgruppen der Phenolether und der Phenethylamine zählt. Die Wirkung wird unter anderem auf die Eigenschaften des 25I-NBOMes als potenter Agonist am Serotonin-Rezeptores 5-HT2A zurückgeführt. 25I-NBOMe ist ein Derivat des 2C-I.
| Property | Value |
|---|---|
| dbo:abstract | 25I-NBOMe (2C-I-NBOMe, Cimbi-5, Smiles and also shortened to "25I") is a synthetic hallucinogen that is used in biochemistry research for mapping the brain's usage of the type 2A serotonin receptor; it is also sometimes used for recreational purposes. A derivative of the substituted phenethylamine 2C-I family, it is the most well-known member of the 25-NB family. It was discovered in 2003 by chemist Ralf Heim at the Free University of Berlin, who published his findings in his PhD dissertation. The compound was subsequently investigated by a team at Purdue University led by David Nichols. The carbon-11 labelled version of 25I-NBOMe, [11C]Cimbi-5, was synthesized and validated as a radiotracer for positron emission tomography (PET) in Copenhagen. Being the first 5-HT2A receptor full agonist PET radioligand, [11C]-CIMBI-5 shows promise as a more functional marker of these receptors, particularly in their high affinity states. Street and media nicknames for this drug are: "N-Bomb", "Solaris", "Smiles", and "Wizard", although the drug is frequently fraudulently sold as LSD. Due to its physical effects and risk of overdose, there have been multiple deaths attributed to the drug. Its long term toxicity is unknown due to lack of existing research. (en) 25I-NBOME (2C-I-NBOME, Cimbi-5) es una droga psicodélica derivada de la feniletilamina sustituida psicodélica . Fue descubierto en 2003 por el químico en la Universidad Libre de Berlín, que publicó sus conclusiones en su tesis doctoral. El compuesto fue posteriormente investigado por un equipo de la Universidad de Purdue dirigido por . La versión marcada con carbono-11 del 25I-NBOME, [11C]CIMBI-5, se sintetizó y se validó como un trazador radioactivo para la tomografía por emisión de positrones (TEP) en Copenhague. Siendo el primer agonista completo del receptor 5-HT2A, para PET, Cimbi-5 promete ser un marcador más funcional de estos receptores, que pueden estar implicados en los trastornos mentales como la depresión y la esquizofrenia. (es) 25I-NBOMe (oder 2C-I-NBOMe) ist eine Forschungschemikalie mit halluzinogener und psychedelischer Wirkung, die aufgrund ihrer Struktur zu den Stoffgruppen der Phenolether und der Phenethylamine zählt. Die Wirkung wird unter anderem auf die Eigenschaften des 25I-NBOMes als potenter Agonist am Serotonin-Rezeptores 5-HT2A zurückgeführt. 25I-NBOMe ist ein Derivat des 2C-I. (de) Le 25I-NBOMe (ou 2C-I-NBOMe, Cimbi-5) est un puissant psychédélique dérivé du 2C-I. Il a été découvert en 2003 par le chimiste Ralf Heim de l'université libre de Berlin, qui a publié ses conclusions dans sa thèse de doctorat. Le composé a ensuite été étudié à l'université de Purdue par David Nichols. (fr) 25I-NBOMe (chiamato anche 2C-I-NBOMe, Cimbi-5 o 25I e colloquialmente come N-Bomb, Solaris, Smiles o Wizard) è una fenitilammina psichedelica oggi utilizzata nella ricerca biochimica per mappare l'uso del cervello del recettore della serotonina di tipo 2A; a volte è anche usata per scopi ricreativi, sebbene presenti rischi considerevolmente più elevati rispetto agli psichedelici classici; nel mercato nero è infatti spesso spacciata per LSD, mescalina o altri psichedelici piuttosto che venduta col suo nome. È un derivato della fenetilammina 2C-I ed è il membro più noto della famiglia dei . È stato scoperto nel 2003 dal chimico della Università di Berlino, che ha pubblicato i suoi risultati nella sua tesi di dottorato. Il composto è stato successivamente esaminato da un team di Università Purdue guidata da David Nichols. È una sostanza molto pericolosa per via delle frequentissime neuropatie di ritorno e la vasocostrizione che generalmente arreca. (it) 25I-NBOMe (2C-I-NBOMe, Cimbi-5, abreviada como 25i) é uma droga psicodélica, descoberta em 2003 pelo químico Ralf Heim da Universidade de Berlim. Foi classificada como droga ilícita pela União Europeia em 25 de setembro de 2014, por não possuir propósito médico ou legítimo. (pt) 25I-NBOMe (2C-I-NBOMe) — психоактивное вещество из класса , производное от 2C-I, синтезированное в 2003 году Ральфом Хеймом (Ralf Heim) в Свободном университете Берлина, в рамках кандидатской диссертации по теме синтеза и фармакологии агонистов серотониновых рецепторов 5-HT2A. 25I-NBOMe действует как сильный полный (селективный) агонист человеческого рецептора 5-HT2A, с Ki равным 0,044 nM, что делает это вещество в 16 раз более активным, чем 2C-I. Также помеченная изотопами форма 25I-NBOMe может быть использована для создания топографии размещения рецепторов 5-HT2A в мозге. Впоследствии вещество изучалось командой университета Пердью под руководством . (ru) |
| dbo:casNumber | 1043868-97-8 919797-19-6 |
| dbo:chEMBL | 1908863 |
| dbo:fdaUniiCode | 0V30416N51 547KGL06IP |
| dbo:pubchem | 10251906 |
| dbo:thumbnail | wiki-commons:Special:FilePath/2C-I-NBOMe-skeletal.svg?width=300 |
| dbo:wikiPageID | 17256523 (xsd:integer) |
| dbo:wikiPageLength | 35061 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1121639290 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:5-HT3 dbr:Potency_(pharmacology) dbr:Purdue_University dbr:Sublabial_administration dbr:David_E._Nichols dbr:Designer_drug dbr:Alkylation dbr:Human dbr:Hypertension dbr:Little_Rock,_Arkansas dbr:Riksdag dbr:Dopamine_receptor_D1 dbr:Dopamine_receptor_D2 dbr:Dopamine_receptor_D3 dbr:Dopamine_receptor_D5 dbr:Dopamine_transporter dbr:Inhalation dbr:Insufflation_(medicine) dbr:Leukoencephalopathy dbr:Δ-opioid_receptor dbr:Intranasal dbc:Designer_drugs dbc:Iodoarenes dbr:Cork_(city) dbr:Creatine_kinase dbr:Analytical_balance dbr:Erowid dbr:Phospholipase_A2 dbr:Free_University_of_Berlin dbr:Grand_Forks,_North_Dakota dbr:Rectal_(medicine) dbr:Lysergic_acid_diethylamide dbr:Magnetic_resonance_imaging dbr:Clonus dbr:Muscarinic_acetylcholine_receptor dbr:2,5-Dimethoxy-4-iodoamphetamine dbr:Acute_kidney_injury dbr:Aggression dbr:Thromboxane_A2 dbr:Dissociation_constant dbr:Head-twitch_response dbr:2C-I dbr:Agonist dbr:Alexander_Shulgin dbr:2C_(psychedelics) dbr:5-HT2A_receptor dbc:25-NB_(psychedelics) dbc:5-HT2A_agonists dbc:5-HT2C_agonists dbr:East_Grand_Forks,_Minnesota dbr:Alpha-1_adrenergic_receptor dbr:European_Union dbr:Cardiac_arrest dbr:Histamine_H1_receptor dbr:Histamine_H2_receptor dbr:Histamine_H3_receptor dbr:Receptor_(biochemistry) dbr:Redox dbr:Hallucinations dbr:Hallucinogen dbr:Ataxia dbr:Ireland dbr:Isotopes_of_carbon dbr:Hydrochloride dbr:Blotting_paper dbr:Tachycardia dbr:Radioactive_tracer dbr:Auditory_hallucination dbr:Phenethylamine dbr:Positron_emission_tomography dbr:Sodium_borohydride dbr:Sodium_triacetoxyborohydride dbr:Metabolic_acidosis dbr:Buccal_administration dbr:Seizures dbr:Medical_Products_Agency_(Sweden) dbr:Microgram dbr:Serotonin_syndrome dbr:Serotonin_transporter dbr:White_blood_cell dbr:Substituted_phenethylamine dbr:Imine dbr:Κ-opioid_receptor dbr:Vasoconstriction dbr:PiHKAL dbr:Intramuscular dbr:Intravenous dbr:Thrombosis dbr:Sublingual_administration dbr:Power_pole dbr:Hyperpyrexia dbr:Serotonin_receptor dbr:2-methoxybenzaldehyde dbr:5-HT1A dbr:5-HT1B dbr:5-HT1D dbr:5-HT1E dbr:5-HT2A dbr:5-HT2B dbr:5-HT2C dbr:5-HT5A dbr:5-HT6 dbr:5-HT7 dbr:25-NB_family dbr:Visual_hallucination dbr:Cardiac_ischemia dbr:Isotopic_labelling dbr:Mu-opioid_receptor |
| dbp:atcPrefix | none (en) |
| dbp:c | 18 (xsd:integer) |
| dbp:casNumber | 919797 (xsd:integer) 1043868 (xsd:integer) |
| dbp:chembl | 1908863 (xsd:integer) |
| dbp:chemspiderid | 8427392 (xsd:integer) |
| dbp:h | 22 (xsd:integer) |
| dbp:i | 1 (xsd:integer) |
| dbp:image | 25 (xsd:integer) |
| dbp:index2Label | dbr:Hydrochloride |
| dbp:iupacName | 2 (xsd:integer) |
| dbp:legalDe | Anlage I (en) |
| dbp:legalEu | Controlled (en) |
| dbp:legalUk | Class A (en) |
| dbp:legalUs | Schedule I (en) |
| dbp:n | 1 (xsd:integer) |
| dbp:o | 3 (xsd:integer) |
| dbp:pubchem | 10251906 (xsd:integer) |
| dbp:routesOfAdministration | Buccal , sublingual, insufflated, inhalation, intravenous, intramuscular, rectal (en) |
| dbp:smiles | COC1=CC=CC=C1CNCCC2=CCOC (en) |
| dbp:stdinchi | 1 (xsd:integer) |
| dbp:stdinchikey | ZFUOLNAKPBFDIJ-UHFFFAOYSA-N (en) |
| dbp:unii | 0 (xsd:integer) 547 (xsd:integer) |
| dbp:verifiedfields | changed (en) |
| dbp:verifiedrevid | 477216002 (xsd:integer) |
| dbp:watchedfields | changed (en) |
| dbp:wikiPageUsesTemplate | dbt:Drugbox dbt:Hallucinogens dbt:LD50 dbt:Phenethylamines dbt:Reflist dbt:Serotonin_receptor_modulators dbt:Short_description dbt:TOC_limit dbt:Cascite dbt:Chemspidercite dbt:Ebicite dbt:Fdacite dbt:Stdinchicite dbt:2C-I_analogues_and_derivatives dbt:N-benzylphenethylamine-Legality-United_Kingdom dbt:Psychedelic_sidebar |
| dcterms:subject | dbc:Designer_drugs dbc:Iodoarenes dbc:25-NB_(psychedelics) dbc:5-HT2A_agonists dbc:5-HT2C_agonists |
| gold:hypernym | dbr:Drug |
| rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Agent114778436 yago:CausalAgent100007347 yago:DesignerDrug103179489 yago:Drug103247620 yago:Hallucinogen103479647 yago:Matter100020827 yago:PhysicalEntity100001930 yago:PsychoactiveDrug104017137 dbo:Drug yago:Substance100020090 yago:WikicatDesignerDrugs yago:WikicatPsychedelicDrugs umbel-rc:DrugProduct |
| rdfs:comment | 25I-NBOMe (oder 2C-I-NBOMe) ist eine Forschungschemikalie mit halluzinogener und psychedelischer Wirkung, die aufgrund ihrer Struktur zu den Stoffgruppen der Phenolether und der Phenethylamine zählt. Die Wirkung wird unter anderem auf die Eigenschaften des 25I-NBOMes als potenter Agonist am Serotonin-Rezeptores 5-HT2A zurückgeführt. 25I-NBOMe ist ein Derivat des 2C-I. (de) Le 25I-NBOMe (ou 2C-I-NBOMe, Cimbi-5) est un puissant psychédélique dérivé du 2C-I. Il a été découvert en 2003 par le chimiste Ralf Heim de l'université libre de Berlin, qui a publié ses conclusions dans sa thèse de doctorat. Le composé a ensuite été étudié à l'université de Purdue par David Nichols. (fr) 25I-NBOMe (2C-I-NBOMe, Cimbi-5, abreviada como 25i) é uma droga psicodélica, descoberta em 2003 pelo químico Ralf Heim da Universidade de Berlim. Foi classificada como droga ilícita pela União Europeia em 25 de setembro de 2014, por não possuir propósito médico ou legítimo. (pt) 25I-NBOMe (2C-I-NBOMe, Cimbi-5, Smiles and also shortened to "25I") is a synthetic hallucinogen that is used in biochemistry research for mapping the brain's usage of the type 2A serotonin receptor; it is also sometimes used for recreational purposes. A derivative of the substituted phenethylamine 2C-I family, it is the most well-known member of the 25-NB family. It was discovered in 2003 by chemist Ralf Heim at the Free University of Berlin, who published his findings in his PhD dissertation. The compound was subsequently investigated by a team at Purdue University led by David Nichols. (en) 25I-NBOME (2C-I-NBOME, Cimbi-5) es una droga psicodélica derivada de la feniletilamina sustituida psicodélica . Fue descubierto en 2003 por el químico en la Universidad Libre de Berlín, que publicó sus conclusiones en su tesis doctoral. El compuesto fue posteriormente investigado por un equipo de la Universidad de Purdue dirigido por . (es) 25I-NBOMe (chiamato anche 2C-I-NBOMe, Cimbi-5 o 25I e colloquialmente come N-Bomb, Solaris, Smiles o Wizard) è una fenitilammina psichedelica oggi utilizzata nella ricerca biochimica per mappare l'uso del cervello del recettore della serotonina di tipo 2A; a volte è anche usata per scopi ricreativi, sebbene presenti rischi considerevolmente più elevati rispetto agli psichedelici classici; nel mercato nero è infatti spesso spacciata per LSD, mescalina o altri psichedelici piuttosto che venduta col suo nome. È un derivato della fenetilammina 2C-I ed è il membro più noto della famiglia dei . È stato scoperto nel 2003 dal chimico della Università di Berlino, che ha pubblicato i suoi risultati nella sua tesi di dottorato. Il composto è stato successivamente esaminato da un team di Università P (it) 25I-NBOMe (2C-I-NBOMe) — психоактивное вещество из класса , производное от 2C-I, синтезированное в 2003 году Ральфом Хеймом (Ralf Heim) в Свободном университете Берлина, в рамках кандидатской диссертации по теме синтеза и фармакологии агонистов серотониновых рецепторов 5-HT2A. 25I-NBOMe действует как сильный полный (селективный) агонист человеческого рецептора 5-HT2A, с Ki равным 0,044 nM, что делает это вещество в 16 раз более активным, чем 2C-I. Также помеченная изотопами форма 25I-NBOMe может быть использована для создания топографии размещения рецепторов 5-HT2A в мозге. (ru) |
| rdfs:label | 25I-NBOMe (de) 25I-NBOMe (en) 25I-NBOMe (es) 25I-NBOMe (it) 25I-NBOMe (fr) 25I-NBOMe (pt) 25I-NBOMe (ru) |
| owl:sameAs | freebase:25I-NBOMe yago-res:25I-NBOMe wikidata:25I-NBOMe http://azb.dbpedia.org/resource/۲۵آی-انبام dbpedia-de:25I-NBOMe dbpedia-es:25I-NBOMe dbpedia-fa:25I-NBOMe dbpedia-fi:25I-NBOMe dbpedia-fr:25I-NBOMe dbpedia-hu:25I-NBOMe dbpedia-it:25I-NBOMe http://lv.dbpedia.org/resource/25I-NBOMe dbpedia-pt:25I-NBOMe dbpedia-ru:25I-NBOMe dbpedia-sh:25I-NBOMe dbpedia-sr:25I-NBOMe https://global.dbpedia.org/id/4Hk9u |
| prov:wasDerivedFrom | wikipedia-en:25I-NBOMe?oldid=1121639290&ns=0 |
| foaf:depiction | wiki-commons:Special:FilePath/25I-NBOMe-spacefill.png wiki-commons:Special:FilePath/2C-I-NBOMe-skeletal.svg |
| foaf:isPrimaryTopicOf | wikipedia-en:25I-NBOMe |
| is dbo:wikiPageRedirects of | dbr:BOM-CI dbr:Cimbi-5 dbr:2C-I-NBOMe dbr:NBOMe-2C-I dbr:NBOMe-2CI dbr:NOBme |
| is dbo:wikiPageWikiLink of | dbr:List_of_designer_drugs dbr:Blacklight dbr:David_E._Nichols dbr:Urban_legends_about_drugs dbr:Presumption_of_supply_in_New_Zealand dbr:NBOMe-mescaline dbr:Lacing_(drugs) dbr:Lysergic_acid_diethylamide dbr:Club_drug dbr:Tolazoline dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:25B-NBOMe dbr:25CN-NBOMe dbr:25D-NBOMe dbr:25E-NBOMe dbr:25G-NBOMe dbr:25H-NBOMe dbr:25I-NB3OMe dbr:25I-NBOH dbr:25N-NBOMe dbr:25P-NBOMe dbr:25TFM-NBOMe dbr:2C-I dbr:2CBFly-NBOMe dbr:25-NB dbr:25E-NBOH dbr:5-HT2A_receptor dbr:5-HT_receptor dbr:List_of_Schedule_I_drugs_(US) dbr:Rave dbr:Isotopes_of_carbon dbr:Blotting_paper dbr:Ehrlich's_reagent dbr:25I dbr:C18H22INO3 dbr:Marquis_reagent dbr:Smiles_(disambiguation) dbr:Neurotoxin dbr:Substituted_phenethylamine dbr:Vasoconstriction dbr:N-bomb dbr:Serotonin_receptor_agonist dbr:BOM-CI dbr:Cimbi-5 dbr:2C-I-NBOMe dbr:NBOMe-2C-I dbr:NBOMe-2CI dbr:NOBme |
| is foaf:primaryTopic of | wikipedia-en:25I-NBOMe |
